Antibiotic usage and costs in the community

Infezioni in Medicina

Volumn 12, Issue 2, 2004, Pages 132-135

  Karatas, Halil ^a   Yalcin, Ata Nevzat ^a   Turgut, Huseyin ^b   Cetin, Banu ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Antibiotics; Cost; Pharmacoeconomics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFAZOLIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; LINCOSAMIDE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; SULTAMICILLIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; COMMUNITY CARE; DRUG COST; DRUG FORMULATION; DRUG MARKETING; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; PHARMACY; PRESCRIPTION; PROSPECTIVE STUDY; TABLET; TURKEY (REPUBLIC);

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DEVELOPING COUNTRIES; DRUG COSTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; MACROLIDES; PENICILLINS; PHARMACIES; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; QUINOLONES; TURKEY;

EID: 3242739293     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Davey P.G., Malek M.M., Parker S.E. Pharmacoeconomics of antibacterial treatment. Pharmacoeconomics. 1 (6), 409-437, 1992.
2. Paladino J.A. Pharmacoeconomics of antimicrobial therapy. Am. J. Health-Syst. Pharm. 56 (Suppl. 3), S25-S28, 1999.
3. Eandi M., Zara G.P., Pepa C.D. Application of pharmacoeconomics to the use of antibiotics. Clin. Microbiol. Infect. 6 (Suppl 3), 90-92, 2000.
4. Reed S.D., Laxminarayan D., Black D.J., Sullivan S.D. Economic issues and antibiotic resistance in the Community. Ann. Pharmacother. 36, 148-154, 2002.
5. Moellering R.C. Jr. Interaction between antimicrobial consumption and selection of resistant bacterial strains. Scand. J. Infect. Dis. 70 (Suppl 1), 18-24, 1990.
6. Bremon A.R., Ruiz-Tovar M., Gorricho B.P., Torres P.D., Rodriguez R.L. Non-hospital consumption of antibiotics in Spain: 1987-1997. J. Antimicrob. Chemother. 45, 395-400, 2000.
7. Cars O., Mölstad S., Melander A. Variation in antibiotic use in the European Union. Lancet 357, 1851-1853, 2001.
8. th Mediterranean Congress of Chemotherapy, Antalya, Turkey, 1996.
9. Mölstad S., Cars O. Major change in the use of antibiotics following a national programme: Swedish strategic programme for the rational use of antimicrobial agents and surveillance of resistance (STRAMA). Scand. J. Infect. Dis. 31, 191-195, 1999.